Merck's NDA For A Pill That Combines Zetia And Lipitor Is Bounced By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Citing a need for more data, the agency refuses to file an NDA for a pill combining ezetimibe (Zetia) and atorvastatin (Pfizer's Lipitor).